Literature DB >> 3625218

Reduction of arginine-vasopressin in the cerebral cortex in Alzheimer type senile dementia.

K Fujiyoshi, H Suga, K Okamoto, S Nakamura, M Kameyama.   

Abstract

Arginine-vasopressin (AVP) concentrations in five cortical areas were measured post mortem in nine patients with senile dementia of Alzheimer's type (SDAT), and compared with the control group of comparable ages. In SDAT patients, AVP was significantly reduced in Brodmann areas 4, 7 and 10 (p less than 0.05). In areas 17 and 22, the detectability and the mean concentrations of AVP were also lower than those of control patients, although not significantly.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3625218      PMCID： PMC1032137          DOI： 10.1136/jnnp.50.7.929

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  25 in total

1.  Radioimmunoassay for GH-release inhibiting hormone.

Authors:  A Arimura; H Sato; D H Coy; A V Schally
Journal:  Proc Soc Exp Biol Med       Date:  1975-03

2.  THE INFLUENCE OF THE POSTERIOR AND INTERMEDIATE LOBE OF THE PITUITARY AND PITUITARY PEPTIDES ON THE MAINTENANCE OF A CONDITIONED AVOIDANCE RESPONSE IN RATS.

Authors:  D DE WIED
Journal:  Int J Neuropharmacol       Date:  1965-05

3.  Arginine vasopressin and choline acetyltransferase in brains of patients with Alzheimer type senile dementia.

Authors:  M N Rossor; L L Iversen; C Q Mountjoy; M Roth; J Hawthorn; V Y Ang; J S Jenkins
Journal:  Lancet       Date:  1980 Dec 20-27       Impact factor: 79.321

4.  CSF and plasma vasopressin concentrations in dementia.

Authors:  P S Sørensen; M Hammer; S Vorstrup; F Gjerris
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-10       Impact factor: 10.154

5.  Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis.

Authors:  P J Whitehouse; D L Price; A W Clark; J T Coyle; M R DeLong
Journal:  Ann Neurol       Date:  1981-08       Impact factor: 10.422

6.  Separation of vasopressin analogues by reversed-phase high-performance liquid chromatography.

Authors:  G Lindeberg
Journal:  J Chromatogr       Date:  1980-05-30

7.  Regional distribution of monoamines in the cerebral cortex and subcortical structures of the rhesus monkey: concentrations and in vivo synthesis rates.

Authors:  R M Brown; A M Crane; P S Goldman
Journal:  Brain Res       Date:  1979-05-18       Impact factor: 3.252

8.  Dopamine-beta-hydroxylase activities in serum and cerebrospinal fluid of aged and demented patients.

Authors:  S Miyata; H Nagata; S Yamao; S Nakamura; M Kameyama
Journal:  J Neurol Sci       Date:  1984-03       Impact factor: 3.181

9.  Vasopressin-immunoreactive cell bodies in the bed nucleus of the stria terminalis of the rat.

Authors:  F van Leeuwen; R Caffé
Journal:  Cell Tissue Res       Date:  1983       Impact factor: 5.249

10.  Extrahypothalamic vasopressin is unchanged in Parkinson's disease and Huntington's disease.

Authors:  M N Rossor; S P Hunt; L L Iversen; R Bannister; J Hawthorn; V T Ang; J S Jenkins
Journal:  Brain Res       Date:  1982-12-16       Impact factor: 3.252
View more
  3 in total

1.  Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on neuropeptide metabolism in the rat brain.

Authors:  K Toide; T Fujiwara; Y Iwamoto; M Shinoda; K Okamiya; T Kato
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-02       Impact factor: 3.000

2.  Pharmacodynamic and pharmacokinetic profile of S 17092, a new orally active prolyl endopeptidase inhibitor, in elderly healthy volunteers. A phase I study.

Authors:  P Morain; J L Robin; G De Nanteuil; R Jochemsen; V Heidet; D Guez
Journal:  Br J Clin Pharmacol       Date:  2000-10       Impact factor: 4.335

3.  Vitamin D interacts with Esr1 and Igf1 to regulate molecular pathways relevant to Alzheimer's disease.

Authors:  Véréna Landel; Pascal Millet; Kévin Baranger; Béatrice Loriod; François Féron
Journal:  Mol Neurodegener       Date:  2016-03-01       Impact factor: 14.195
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.